Detalles de la búsqueda
1.
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumors.
Invest New Drugs
; 38(1): 120-130, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30887250
2.
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab.
Br J Clin Pharmacol
; 82(6): 1568-1579, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530379
3.
Development of a Highly Specific Anti-drug Antibody Assay in Support of a Nanoparticle-based Therapeutic.
AAPS J
; 22(4): 81, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488626
4.
Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis.
Clin Transl Sci
; 13(6): 1288-1297, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32583962
5.
Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007-2017.
BMJ Open
; 10(10): e036341, 2020 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33039986
6.
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea.
Clin Transl Sci
; 13(5): 916-922, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166908
7.
A Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for Bococizumab, a Humanized Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, and Its Application in Early Clinical Development.
J Clin Pharmacol
; 57(7): 855-864, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181260
8.
Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine.
Evid Based Complement Alternat Med
; 2014: 364819, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24899907
Resultados
1 -
8
de 8
1
Próxima >
>>